First human safety study of MT-251 in healthy volunteers
This is the first human study of a new medication called MT-251. It is a safety study, so healthy volunteers are given either a single dose or multiple doses of the drug to see how the body handles it and if there are any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 to 55 years old.
- You are in good general health, with no major medical problems.
- You have not used any tobacco or nicotine products (like cigarettes, vaping, or gum) for at least 3 months.
- If you are a female, you are past menopause or have had surgery to prevent pregnancy.
- You have not taken any prescription drugs in the last 21 days, or over-the-counter drugs in the last 7 days (except as allowed by the study doctor).
- You have not donated blood within the last 60 days or plasma within the last 14 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called MTX-101 in healthy volunteers to see if it is safe and how the body processes it. It helps determine the right dose before testing in patients with certain conditions.
This study tests a new oral medication, TESP-0401, in healthy volunteers to check its safety, how the body processes it, and any side effects. It is a first-in-human trial, so participants help determine if the drug is safe enough for future studies.
This trial tests a new drug, TL-001, in healthy volunteers to see if it is safe and how the body processes it. You may join if you are a healthy adult between 18 and 55.
This study tests a new oral medication, VG290131, in healthy volunteers to see how the body processes it and if it is safe. It is an early-phase trial that requires participants to be in good health and follow specific rules about medications and lifestyle.
This trial tests a new medicine called MT-201 to see if it is safe and how the body handles it. It is for healthy volunteers aged 19 to 55 who are willing to follow study rules.
This study tests a new experimental drug called MT-201 when given with an existing medicine (infliximab) to healthy people. It helps doctors learn how the drugs work in the body and whether they are safe.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.